(Q44706671)

5 December 2017

title

Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence (English)

1 reference

5 December 2017

1 reference

1

Takashi Uchiyama

1 reference

5 December 2017

10

Hitoshi Nakagama

1 reference

5 December 2017

11

Atsushi Nakajima

1 reference

5 December 2017

2

Hirokazu Takahashi

1 reference

5 December 2017

3

Hiroki Endo

1 reference

5 December 2017

8

Masahiko Inamori

1 reference

5 December 2017

7

Masato Yoneda

1 reference

5 December 2017

6

Kunihiro Hosono

1 reference

5 December 2017

9

Yoshitaka Hippo

1 reference

5 December 2017

Shingo Kato

4

1 reference

5 December 2017

Eiji Sakai

series ordinal

5

1 reference

5 December 2017

language of work or name

1 reference

2 April 2012

1 reference

5 December 2017

1 reference

5 December 2017

volume

24

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

353-357

1 reference

Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Lessons from hereditary colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Aberrant crypt foci of the colon as precursors of adenoma and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

A multicenter study of prevalence and risk factors for aberrant crypt foci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Aberrant crypt foci in the adenoma prevention with celecoxib trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

The association of physical activity and body mass index with the risk of large bowel polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

Increased frequency of serrated aberrant crypt foci among smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

The Yield of Surveillance Colonoscopy by Adenoma History and Time to Examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-1661.2012.01289.X

10.1111/J.1443-1661.2012.01289.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference